Table 2.

Lung Cancer Screening Opinions by Provider Specialty

Statement	Pulmonologists N = 17		Primary Care Providers N = 72		P value
	N	%	N	%
I am convinced that screening for lung cancer is beneficial for patients
Strongly agree	6	35.3	4	5.8	< .001
Agree	9	52.9	22	31.9
Undecided	2	11.8	33	47.8
Disagree	0	0	10	14.5
Strongly disagree	0	0	0	0
Missing	0	–	3	–
Inconsistent recommendations about lung cancer screening make it difficult to decide whether or not to screen
Strongly agree	2	11.8	8	11.4	.575
Agree	5	29.4	34	48.6
Undecided	2	11.8	7	10.0
Disagree	7	41.2	18	25.7
Strongly disagree	1	5.9	3	4.3
Missing	0	–	2	–
Screening for lung cancer is cost-effective
Strongly agree	0	0	1	1.4	.026
Agree	8	47.1	9	12.9
Undecided	8	47.1	41	58.6
Disagree	1	5.9	11	15.7
Strongly disagree	0	0	8	11.4
Missing	0	–	2	–
I rely on the recommendations of local specialists regarding lung cancer screening in my practice
Strongly agree	3	19.7	0	0	< .001
Agree	9	52.9	16	23.2
Undecided	0	0	12	17.4
Disagree	5	29.4	35	50.7
Strongly disagree	0	0	6	8.7
Missing	0	–	3	–
I have enough knowledge to explain the pros and cons of lung cancer screening to my patients
Strongly agree	4	25.0	9	13.0	.221
Agree	9	56.3	33	47.8
Undecided	3	18.8	12	17.4
Disagree	0	0	14	20.3
Strongly disagree	0	0	1	1.5
Missing	1	–	3	–
Time restrictions during a patient’s clinic visit mean other presenting problems have higher priority than screening for lung cancer
Strongly agree	2	11.8	10	14.7	.017
Agree	5	29.4	36	52.9
Undecided	7	41.2	8	11.8
Disagree	2	11.8	14	20.6
Strongly disagree	1	5.9	0	0
Missing	0	–	4	–